Metabolites derived from any human flavin-containing monooxygenase (FMO) subtype can now be produced as a service offering at Hypha. Recombinant… read more →
Great to see Hypha recognised for producing a glucuronide metabolite of praliciguat (M3) in the paper just out in the… read more →